RecruitingNCT05759117

Prospective Evaluation of Patients With Pleural Effusion

Prospective Evaluation of the Aetiologies, Management and Clinical Outcomes in Patients With Pleural Effusion


Sponsor

Chinese University of Hong Kong

Enrollment

1,000 participants

Start Date

Sep 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Having a pleural effusion is a common reason for being hospitalized, as it usually requires in-patient care for invasive diagnostic and therapeutic procedures. Specific subtypes of pleural effusion may warrant recurrent admissions, a longer hospital stay and consume more healthcare resources. Despite the recent advancement of pleural medicine, better research is increasingly desired to fill the gaps in establishing an early diagnosis and optimal management of pleural effusion from various causes. Local data on different aspects of pleural effusion is also lacking.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called thoracentesis for people with pleural effusion. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREthoracentesis

A type of pleural procedure that will yield pleural fluid for subsequent analysis


Locations(2)

Chinese University of Hong Kong

Hong Kong, Hong Kong, Hong Kong

Prince of Wales Hospital

Hong Kong, Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05759117


Related Trials